Airway Management Devices Market Share, Size and Forecast 2022-2027
IMARC Group’s latest research report, titled “Airway Management Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global airway management devices market size reached US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 7.1% during 2022-2027.
Airway Management Devices Uses:
Airway management devices are used for maintaining or restoring ventilation in a patient. They also include evaluating, planning, and using different medical procedures to treat patients with respiratory failures or acute obstruction. Besides this, airway management devices protect the lungs from injury and provide gas exchange facilities to patients. Some of the most commonly utilized management devices to keep the upper airway open for offering unobstructed ventilation are supraglottic airway devices (SADs), tracheal intubation, transtracheal access, and airway clearance.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/airway-management-devices-market/requestsample
Competitive Landscape with Key Players:
- Ambu A/S
- Armstrong Medical Ltd
- Becton Dickinson and Company
- Flexicare (Group) Limited
- Intersurgical Ltd
- Medline Industries Inc
- Medtronic plc
- Mercury Enterprises Inc
- Smiths Group plc
- Teleflex Incorporated
- VBM Medizintechnik GmbH
- Verathon Inc. (Roper Technologies Inc.)
Airway Management Devices Market Demand and Growth:
The growing prevalence of respiratory diseases, owing to numerous individuals suffering from chronic obstructive pulmonary disease (COPD) and asthma, is among the key factors stimulating the airway management devices market. Moreover, the inflating utilization of anesthesia during surgical procedures, on account of the rising number of surgeries across the globe, is acting as another significant growth-inducing factor. Besides this, the increasing usage of management devices, owing to several benefits, such as the high efficiency in airway clearance, maintenance of proper ventilation, and patient safety during operative procedures, is positively influencing the global market.
Furthermore, the rising need for emergency therapy for prolonged illness and protracted treatment associated with lung diseases in children and adults is also propelling the market growth. Apart from this, the introduction of advanced techniques for preoperative airway evaluation is further fueling the global market. Additionally, the widespread adoption of these airway devices, as they provide easy tracheal placement resulting in improved patient safety and are subsequently used in a range of clinical applications, is anticipated to fuel the airway management devices market over the forecasted period.
Browse Full Report With TOC: https://www.imarcgroup.com/airway-management-devices-market
Key Market Segmentation:
Breakup by Product:
- Supraglottic Devices
- Oropharyngeal Devices
- Naspharyngeal Devices
- Laryngeal Airway Devices
- Others
- Infraglottic Devices
- Endotracheal Tubes
- Tracheostomy Tubes
- Others
- Resuscitators
- Laryngoscopes
- Others
Breakup by Patient Type:
- Adult
- Pediatric Patient/Neonates
Breakup by Application:
- Anesthesia
- Emergency Medicine
- Others
Breakup by End Use:
- Hospitals
- Homecare
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
